Sort
48,018 grants matching “immunotherapy”
Stanford Project 2
$516,569Calvin J Kuo · University Of California, San Francisco · U54 · FY2021 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$516,407Gordon B. Mills · Oregon Health & Science University · U01 · FY2022 · CA
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
$516,386Aaron M Newman · Stanford University · R01 · FY2021 · CA
TARGETING IMMUNOTHERAPY-RESISTANT LESIONS TO ERADICATE OLIGOMETASTATIC PROSTATE CANCER
$516,366University Of Wisconsin System · · FY2024 · Defense Health Agency
Core 3: Mouse Models Core (MM Core)
$516,360Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2023 · CA
Immunoengineering Strategies for Musculoskeletal Trauma
$516,331Robert E Guldberg · University Of Oregon · R01 · FY2020 · AR
Acute Kidney Injury and Double Negative T Cells
$516,264Abdel Hamad · Johns Hopkins University · R01 · FY2020 · DK
Advancing T cell Therapy for Ovarian Cancer
$516,260George Coukos · Fox Chase Cancer Center · P50 · FY2011 · CA
Molecular Basis of CD1D and Natural Killer T Cell Function
$516,236Sebastian Joyce · Vanderbilt University Medical Center · R01 · FY2021 · AI
Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions
$516,221Ernest Fraenkel · Massachusetts Institute Of Technology · U01 · FY2024 · CA
Nanoparticles-mediated combination therapy for breast cancer
$516,189Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
$516,185David H Canaday · Case Western Reserve University · R01 · FY2010 · AI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$516,179Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2023 · CA
Understanding the genetic and immunologic basis of autoimmune hemolytic anemia (AIHA) in a novel canine model system
$516,056Steven Gene Friedenberg · University Of Minnesota · R01 · FY2025 · HL
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
$516,038Scott Andrew Gerber · University Of Rochester · R01 · FY2022 · CA
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
$516,038Scott Andrew Gerber · University Of Rochester · R01 · FY2021 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$516,032Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2023 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$516,032Chuan-Yuan Li · Duke University · R01 · FY2022 · CA
IDO1 and Immunotolerance in Glioblastoma
$515,890Derek Alan Wainwright · Loyola University Chicago · R01 · FY2023 · NS
Improving T cell Production through Mechanometabolism and Control of Nutrient Availability
$515,885Lance C Kam · Columbia University · · FY2024 · ENG
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
$515,747Aaron M Newman · Stanford University · R01 · FY2025 · CA
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
$515,747Aaron M Newman · Stanford University · R01 · FY2022 · CA
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
$515,673Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
$515,611Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Development of mAb therapeutics against biothreat and emerging diease agents
$515,568Thomas Briese · Columbia University Health Sciences · U54 · FY2010 · AI